Sugar-sweetened beverages and cardio-metabolic disease risks
- 1 July 2013
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 16 (4) , 478-484
Abstract
Sucrose-sweetened beverages (SSB) have for decades been implicated in cardiometabolic diseases. The purpose of this review is to summarize recent epidemiological but particularly recent human intervention studies on the metabolic effects associated/induced by SSB. Recent epidemiological studies support the positive association between SSB intake and enhanced risk for metabolic syndrome, type 2 diabetes, coronary heart diseases, and stroke. From the human intervention studies rather similar results are obtained with enhanced accumulation of fat in the liver, muscle, and in the visceral fat depot induced by SSB. Moreover, SSB induces enhanced levels of circulating triglycerides and enhanced de-novo lipogenesis in the liver. The specific effect of SSB on body weigh/obesity is still not completely elucidated but SSB enhances body weight/fat mass even though not to a significant degree in all studies. Concerning the mechanisms for SSB to induce these metabolic aberrations most of the studies are in agreement with the fact that it is mainly fructose (free or as part of the sucrose molecule) that is the main driver of these metabolic aberrations presumably primarily by inducing lipid synthesis in and release from the liver. There are now convincing evidences for enhanced cardiometabolic risk after higher intake of SSB where both epidemiological studies and human intervention studies are pointing in the same direction. A so-called 'well tolerated' intake of SSB is not determined. Accordingly, intake of SSB should generally be reduced as much as possible to improve the health of the population.Keywords
This publication has 33 references indexed in Scilit:
- Caffeinated and caffeine-free beverages and risk of type 2 diabetesThe American Journal of Clinical Nutrition, 2013
- Fructose and Risk of Cardiometabolic DiseaseCurrent Atherosclerosis Reports, 2012
- Greater Fructose Consumption Is Associated with Cardiometabolic Risk Markers and Visceral Adiposity in Adolescents3The Journal of Nutrition, 2012
- Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in menThe American Journal of Clinical Nutrition, 2011
- Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 DiabetesDiabetes Care, 2010
- Sugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease RiskCirculation, 2010
- Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults in the CommunityCirculation, 2007
- Intake of sugar-sweetened beverages and weight gain: a systematic reviewThe American Journal of Clinical Nutrition, 2006
- Sugar-Sweetened Beverages, Weight Gain, and Incidence of Type 2 Diabetes in Young and Middle-Aged WomenJAMA, 2004
- The Association of Caffeinated Beverages With Blood Pressure in AdolescentsArchives of Pediatrics & Adolescent Medicine, 2004